Pharmaceutical Biotech (02269) issued an announcement to repurchase 2.261,000 shares at HK$31.967 million on May 13, 2024.
On May 13, 2024, 107,000 shares were issued as a result of the exercise of options under the share options plan.
药明生物(02269)发布公告,于2024年5月13日斥资3196.7万港元回购226.1万股。
于2024年5月13日因根据股份期权计划行使期权而发行10.7万股。
Pharmaceutical Biotech (02269) issued an announcement to repurchase 2.261,000 shares at HK$31.967 million on May 13, 2024.
On May 13, 2024, 107,000 shares were issued as a result of the exercise of options under the share options plan.
Use the share button in your browser
to share the page with your friends